PMID- 24954331 OWN - NLM STAT- MEDLINE DCOM- 20150409 LR - 20221207 IS - 1976-2437 (Electronic) IS - 0513-5796 (Print) IS - 0513-5796 (Linking) VI - 55 IP - 4 DP - 2014 Jul TI - Resolution of ambiguous HLA genotyping in korean by multi-group-specific sequence-based typing. PG - 1005-13 LID - 10.3349/ymj.2014.55.4.1005 [doi] AB - PURPOSE: To evaluate a multi-group-specific sequence-based typing (SBT) method for resolving ambiguous results from human leukocyte antigen (HLA) genotyping. MATERIALS AND METHODS: A total of 50 samples that showed ambiguous genotypes for at least two HLA loci from HLA-A, -B, -C and -DRB1 by the conventional SBT assay were evaluated using a new SBT test, the AVITA plus assay. The most likely HLA genotypes for the respective samples considering allele frequencies in Korean were concordant between the AVITA and conventional SBT assays. RESULTS: An average of 3.3 loci among the HLA-A, -B, -C and -DRB1 loci per sample gave results with two or more possible allele combinations with the conventional SBT, and 48 (96.0%) out of 50 showed reduced numbers of possible genotypes for at least one HLA locus with the AVITA. A total of 41, 43, 42, and 38 cases among the 50 samples showed ambiguous results for HLA-A, -B, -C, and -DRB1 typing by the conventional SBT, respectively. The average numbers of possible allele combinations for the respective four HLA loci were 8.2, 6.7, 5.9, and 3.2, and they were reduced to 1.5, 2.2, 4.4, and 1.8, respectively, by the AVITA. Ambiguity was resolved by the AVITA in 33 (80.5%), 31 (72.1%), 17 (40.5%) and 28 (73.7%) samples among the ambiguous cases from the conventional SBT for HLA-A, -B, -C, and -DRB1 typing, respectively. CONCLUSION: The multi-group-specific SBT method considerably reduced the number of ambiguous results, and thus may be useful for accurate HLA typing in clinical laboratories. FAU - Park, Yongjung AU - Park Y AD - Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Yoon, Cha Eun AU - Yoon CE AD - Biowithus Life Science Institute, Seoul, Korea. FAU - Kwon, Oh-Joong AU - Kwon OJ AD - College of Animal Bioscience & Technology, Konkuk University, Seoul, Korea. FAU - Kim, Yu-Seun AU - Kim YS AD - Division of Transplantation Surgery, Department of Surgery,The Research Institute for Transplantation, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Kim, Hyon-Suk AU - Kim HS AD - Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. kimhs54@yuhs.ac. LA - eng PT - Journal Article PL - Korea (South) TA - Yonsei Med J JT - Yonsei medical journal JID - 0414003 RN - 0 (HLA Antigens) SB - IM MH - Asian People/genetics MH - Base Sequence MH - Gene Frequency/genetics MH - Genotype MH - HLA Antigens/*genetics MH - Histocompatibility Testing MH - Humans MH - Polymerase Chain Reaction PMC - PMC4075361 OTO - NOTNLM OT - Human leukocyte antigen OT - ambiguity OT - high resolution OT - multi-group-specific PCR OT - sequence-based typing COIS- The authors have no financial conflicts of interest. EDAT- 2014/06/24 06:00 MHDA- 2015/04/10 06:00 PMCR- 2014/07/01 CRDT- 2014/06/24 06:00 PHST- 2014/06/24 06:00 [entrez] PHST- 2014/06/24 06:00 [pubmed] PHST- 2015/04/10 06:00 [medline] PHST- 2014/07/01 00:00 [pmc-release] AID - 2014071005 [pii] AID - 10.3349/ymj.2014.55.4.1005 [doi] PST - ppublish SO - Yonsei Med J. 2014 Jul;55(4):1005-13. doi: 10.3349/ymj.2014.55.4.1005.